ATE516018T1 - Injizierbare sterile pharmazeutische zusammensetzung mit piperacillin-natrium und tazobactam-natrium als wirkstoffe - Google Patents
Injizierbare sterile pharmazeutische zusammensetzung mit piperacillin-natrium und tazobactam-natrium als wirkstoffeInfo
- Publication number
- ATE516018T1 ATE516018T1 AT07122822T AT07122822T ATE516018T1 AT E516018 T1 ATE516018 T1 AT E516018T1 AT 07122822 T AT07122822 T AT 07122822T AT 07122822 T AT07122822 T AT 07122822T AT E516018 T1 ATE516018 T1 AT E516018T1
- Authority
- AT
- Austria
- Prior art keywords
- sodium
- pharmaceutical composition
- sterile pharmaceutical
- composition containing
- active ingredients
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- TUPFOYXHAYOHIB-YCAIQWGJSA-M sodium;(2s,5r,6r)-6-[[(2r)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2s,3s,5r)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]h Chemical compound [Na+].C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1.O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 TUPFOYXHAYOHIB-YCAIQWGJSA-M 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000568A ITMI20070568A1 (it) | 2007-03-22 | 2007-03-22 | Comosizione farmaceutica sterile iniettabile avente piperacillina sodica e tazobactam sodico come principi attivi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516018T1 true ATE516018T1 (de) | 2011-07-15 |
Family
ID=39673190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07122822T ATE516018T1 (de) | 2007-03-22 | 2007-12-11 | Injizierbare sterile pharmazeutische zusammensetzung mit piperacillin-natrium und tazobactam-natrium als wirkstoffe |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8765190B2 (de) |
| EP (1) | EP1974721B1 (de) |
| AT (1) | ATE516018T1 (de) |
| DK (1) | DK1974721T3 (de) |
| ES (1) | ES2369441T3 (de) |
| IT (1) | ITMI20070568A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| KR102329764B1 (ko) | 2013-03-15 | 2021-11-23 | 머크 샤프 앤드 돔 코포레이션 | 세프톨로잔 항균성 조성물 |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| US20140274991A1 (en) | 2013-03-15 | 2014-09-18 | Cubist Pharmaceuticals, Inc. | Ceftolozane pharmaceutical compositions |
| EP3043797B1 (de) | 2013-09-09 | 2020-04-08 | Merck Sharp & Dohme Corp. | Behandlung von infektionen mit ceftolozan/tazobactam bei personen mit beeinträchtigter nierenfunktion |
| US20150094293A1 (en) | 2013-09-27 | 2015-04-02 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
| CN115554298A (zh) * | 2021-07-01 | 2023-01-03 | 北京诺康达医药科技股份有限公司 | 一种他唑巴坦和哌拉西林的联合制剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2925963A1 (de) * | 1979-06-27 | 1981-01-22 | Bayer Ag | Penicillin-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel |
| AU2003230899A1 (en) | 2003-04-14 | 2004-11-26 | Wyeth Holdings Corporation | Compositions containing piperacillin and tazobactam useful for injection |
| CN1913890A (zh) * | 2004-01-30 | 2007-02-14 | 惠氏公司 | 大体上不含半乳甘露聚糖且含有哌拉西林(piperacillin)和他唑巴坦(tazobactam)的组合物 |
| MX2007004490A (es) | 2004-10-14 | 2007-05-08 | Wyeth Corp | Composiciones que contienen piperacilina, tazobactam y un acido aminocarboxilico en un diluyente de lactato de sodio. |
| ITMI20051630A1 (it) * | 2005-09-02 | 2007-03-03 | Acs Dobfar Spa | Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi |
-
2007
- 2007-03-22 IT IT000568A patent/ITMI20070568A1/it unknown
- 2007-12-06 US US11/951,589 patent/US8765190B2/en active Active
- 2007-12-11 EP EP07122822A patent/EP1974721B1/de not_active Not-in-force
- 2007-12-11 ES ES07122822T patent/ES2369441T3/es active Active
- 2007-12-11 AT AT07122822T patent/ATE516018T1/de active
- 2007-12-11 DK DK07122822.5T patent/DK1974721T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DK1974721T3 (da) | 2011-10-24 |
| ES2369441T3 (es) | 2011-11-30 |
| ITMI20070568A1 (it) | 2008-09-23 |
| US8765190B2 (en) | 2014-07-01 |
| EP1974721B1 (de) | 2011-07-13 |
| EP1974721A1 (de) | 2008-10-01 |
| US20080233196A1 (en) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE516018T1 (de) | Injizierbare sterile pharmazeutische zusammensetzung mit piperacillin-natrium und tazobactam-natrium als wirkstoffe | |
| AR110986A2 (es) | Composiciones de ecteinascidina, formulaciones liofilizadas, método de preparación y uso | |
| ATE499090T1 (de) | Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan | |
| PA8565501A1 (es) | Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas | |
| WO2007121256A3 (en) | Rapid acting and long acting insulin combination formulations | |
| AP2002002552A0 (en) | Pharmaceutical compositions providing enhanced drug concentrations. | |
| DE602007010254D1 (de) | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack | |
| CL2012003197A1 (es) | Formulación farmacéutica acuosa que comprende 200-1000 u/ml de insulina glargina, con condición de que la concentración de dicha formulación no sea 684 u/ml de insulina glargina; y su uso para tratar diabetes mellitus de tipo i y tipo ii en un paciente. | |
| ATE430564T1 (de) | Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln | |
| CY1114499T1 (el) | Βιοδιαθεσιμες στερεες δοσολογικες μορφες μεταξαλονης | |
| CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
| AR049063A1 (es) | Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas | |
| CO6300932A2 (es) | Composicion solida termoestable que comprende sustancias mejoradas de permeabilidad para ingredientes farmaceuticos activos de permeabilidad deficiente | |
| AR117718A2 (es) | Mejoramientos en composiciones farmacéuticas, y relacionados con ellas | |
| RU2012100622A (ru) | Композиция для инъекций, содержащая гидроксихлорохин, для местного применения при лечении рака | |
| MXPA05014232A (es) | Composiciones farmaceuticas estables de 5,10-metilentetrahidrofolato. | |
| DE602006019320D1 (de) | Biologisch wirksame zusammensetzung mit ethylcellulose | |
| ATE367165T1 (de) | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen | |
| BRPI0606119B8 (pt) | preparações injetáveis de diclofenaco e seus sais farmaceuticamente aceitáveis | |
| DE60219963D1 (de) | Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes | |
| ATE291421T1 (de) | Pharmazeutische, ramipril enthaltende brauseformulierung | |
| AR051727A1 (es) | Formulacion oral de liberacion inmediata de una sustancia activa poco soluble en agua | |
| AR072889A1 (es) | Combinacion coccidicida para uso veterinario | |
| DK2252263T3 (da) | Galenisk form til oral transmukosal indgivelse af triptaner | |
| CR8973A (es) | Composicion farmaceutica en forma de una forma de dosificacion solida soluble en agua |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1974721 Country of ref document: EP |